The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT.
J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
High-density lipoprotein turnover.
Nestel PJ.
Am Heart J. 1987 Feb;113(2 Pt 2):518-21. doi: 10.1016/0002-8703(87)90624-7.
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.
Kesaniemi YA, Grundy SM.
JAMA. 1984 May 18;251(19):2542-7.
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
Packard CJ, Shepherd J, Joerns S, Gotto AM Jr, Taunton OD.
Biochim Biophys Acta. 1979 Feb 26;572(2):269-82. doi: 10.1016/0005-2760(79)90042-0.
Models and mechanisms in very low density lipoprotein metabolism.
Packard CJ, Shepherd J.
Eur J Clin Invest. 1985 Apr;15(2):51-2. doi: 10.1111/j.1365-2362.1985.tb00143.x.
Familial hypertriglyceridemia/polygenic hypertrigliceridemia.
Lahoz C, Mostaza JM.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:37-42. doi: 10.1016/j.arteri.2020.12.014.
Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S.
Arterioscler Thromb. 1991 Jul-Aug;11(4):864-71. doi: 10.1161/01.atv.11.4.864.
Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.
Dunn FL, Grundy SM, Bilheimer DW, Havel RJ, Raskin P.
Metabolism. 1985 Apr;34(4):316-24. doi: 10.1016/0026-0495(85)90220-3.
Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemia.
Brook JG, Torsvik H, Lees RS, McCluskey MA, Feldman HA.
Metabolism. 1979 Jan;28(1):4-8. doi: 10.1016/0026-0495(79)90161-6.
